
Flogat 150mg Tablet
Marketer
Daxia Healthcare
Salt Composition
Dabigatran Etexilate (150mg)
Overview Flogat 150mg Tablet
CardioThin 150mg tablets function as an anticoagulant, preventing and treating blood clots to mitigate the risk of stroke and heart attack. This medication inhibits clot formation in leg, lung, brain, and heart veins. Frequently prescribed for patients with atrial fibrillation to prevent clot formation, CardioThin 150mg is also used post-knee or hip replacement to reduce clotting risk. Administration is flexible—with or without food—but consistent daily timing is advised. Long-term use, potentially lifelong, may be necessary; discontinuation or dosage alteration should only occur under physician supervision to avoid increased risk of stroke, heart attack, or thrombosis. Lifestyle modifications, including cessation of smoking, a balanced diet, regular exercise, and weight management (if needed), further reduce clot risk. Common side effects include gastrointestinal discomfort and increased bleeding susceptibility (e.g., nosebleeds, bruising). Report any adverse effects immediately. Other potential side effects encompass headaches, seizures, allergic reactions, visual disturbances, and fatigue. Contraindications include severe hepatic or renal impairment, active bleeding, and concurrent use of other anticoagulants. Breastfeeding is not recommended during treatment. Unlike some anticoagulants, routine PT-INR monitoring is unnecessary.
Uses of Flogat 150mg Tablet
Managing and preventing venous thromboembolism
Major Benefits of Flogat 150mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the 150mg Flogat tablet whole; avoid chewing, crushing, or fracturing it. While consumption with or without food is acceptable, consistent daily timing is recommended for optimal results.
Common Side effects of Flogat 150mg Tablet:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Flogat 150mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 150mg Flogat tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
How Flogat 150mg Tablet works:
Xylothin 150mg tablets are a new oral anticoagulant, inhibiting blood clot development.
SAFETY ADVICE
AlcoholUNSAFE
Combining Flogat 150mg Tablet with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Flogat 150mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Using Flogat 150mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Flogat 150mg Tablets.
KidneyCAUTION
Individuals with severe kidney impairment should exercise caution when using Flogat 150mg tablets, as dose modification may be necessary. Medical advice is recommended. Flogat 150mg tablets are generally unsuitable for patients with severe kidney disease.
LiverCAUTION
Individuals with hepatic impairment should exercise prudence when using Flogat 150mg tablets. Dosage modification for Flogat 150mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Flogat 150mg Tablet :
Should you forget a Flogat 150mg Tablet dose, ingest it immediately if still within the same day. However, omit the missed dose if it's less than six hours until your next scheduled intake. Never compensate for a missed dose by taking double the prescribed amount.
Facts to Know About Flogat 150mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Action Class | Oral direct thrombin inhibitor |
